The purpose of this study is to evaluate the effect of food on the pharmacokinetic characteristics of fenofibric acid for HIP0901 capsule.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
48
The study drug(HIP0901 capsule(Fenofibric acid, 135mg)) will be administrated under fed or fasting conditions
Korea University Anam Hospital
Seoul, South Korea
AUC of Fenofibric acid
Time frame: 0-96 hrs
Cmax of Fenofibric acid
Time frame: 0-96 hrs
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.